Recovery
Research-onlyBPC-157 / TB-500 5MG / 5MG
A research combination of two peptides studied in tissue-repair models.
What is BPC-157 / TB-500?
This vial contains two separate research peptides: BPC-157 (a synthetic fragment related to a stomach-protective protein) and TB-500 (a fragment related to thymosin beta-4). Both are studied in laboratory and animal models of tissue repair. Neither is an FDA-approved medicine.
BPC-157 is a synthetic 15-amino-acid sequence derived from a portion of body-protection compound found in gastric juice; preclinical work explores angiogenesis and tissue-healing pathways. TB-500 corresponds to an active region of thymosin beta-4, a peptide involved in actin regulation and cell migration. Human clinical evidence is very limited; most data are preclinical.
Why researchers study it
Evidence varies by area. We label each honestly and avoid guaranteed health claims.
Tissue repair / angiogenesis (BPC-157)
Preclinical evidencePrimarily animal-model data.
Cell migration / actin regulation (TB-500)
Preclinical evidenceMechanistic and animal-model data.
How it works
A simplified view — understandable with zero medical background.
Signal
Each peptide interacts with pathways involved in cell migration and repair.
Pathway
Preclinical models describe effects on angiogenesis and tissue remodeling.
Response
Repair-related outcomes are studied in laboratory settings.
Storage, handling & safety
Storage
Lyophilized peptides are typically stored cold and protected from light. Follow product documentation.
Handling
Keep the vial labeled and use clean laboratory technique on a clean surface.
Safety
Investigational research materials. Not established as safe or effective for personal use. Discuss recovery or injury concerns with a qualified clinician.
Supplies & preparation (education)
General educational descriptions only. This does not tell you which syringe to use for a specific compound, and does not turn supply sizes into dosing guidance.
- ✓
Alcohol Prep Pads
Individually wrapped alcohol wipes used to clean surfaces in a general research context.
- ✓
3 mL Sterile Syringes
3 mL syringes are commonly used for transferring measured liquid in laboratory settings. This is a general description, not a recommendation about administering any compound.
- ✓
FDA-Cleared Sharps Disposal Container
A puncture-resistant container cleared for the disposal of sharps.
- ✓
Labels
Labels for keeping vials and containers clearly identified with contents and date.
Preparation guide
Reconstitution information published by NextGen for this product, with the concentration worked out. This is preparation education — not a personal dose or schedule.
Standard
Provided by NextGenVial strength
10 mg
Add bacteriostatic water
3 mL
Resulting concentration
3.33 mg/mL
Adding 3 mL of bacteriostatic water to a 10 mg lyophilized powder vial gives a concentration of 3.33 mg/mL — that is, every 1 mL of the mixed liquid contains 3.33 mg. This is the arithmetic of the values NextGen published.
Preparation notes
Mix and use 10 units in injury spot if its a injectable spot (shoulder, hip, stomach area, whatever is closest to your injury.
After mixing: Keep in fridge.
Preparation information published by NextGen. This describes how to reconstitute the vial — it is not a personal dose, injection amount, or schedule. Always follow the directions given to you by a qualified professional and verify against the markings on your own supplies.
Watch & learn
Relevant third-party educational videos. Independent sources — not medical advice or an endorsement.
What people commonly report
Research reviewed: continuously updated by an administrator.
Questions about BPC-157 / TB-500?
NextGen AI can answer research-education questions using approved sources.